Taiwan Food and Drug Administration (TFDA) collaborates with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host the 12th Joint Conference of Taiwan and Japan on Medical Products Regulation on October 7th, 2024 in Tokyo, Japan. The conference aims to facilitate the exchange of regulatory information, promote cooperation between officials and industries from both sides, and support industry growth in international markets, all while prioritizing public health and well-being.

Since the “Framework of Cooperation on Medical Products Regulation” was signed by the Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, both sides have alternated hosting Joint Conferences annually for 12 years. This year, representatives from TFDA, MHLW and PMDA will share the latest information on medical product regulations, as well as discuss important topics such as “Improving patient access to innovative drugs and ensuring sustainable supply,” “Regulations on biosimilar products,” and “Latest updates on CADe/CADx medical device review requirements and recent innovations and developments.” The conference, attended by nearly 200 officials and industry representatives from both sides, is being held in person. We hope that through this conference, both sides will gain a better understanding of regulations and create a new blueprint for collaboration between Taiwan and Japan on medical product regulations.